Clinical utility of transthoracic echocardiography for screening abdominal aortic aneurysm: a prospective study in a Japanese population by Yoshihisa Matsumura et al.
RESEARCH Open Access
Clinical utility of transthoracic
echocardiography for screening abdominal
aortic aneurysm: a prospective study in a
Japanese population
Yoshihisa Matsumura1*, Michiko Wada2, Daigo Hirakawa2, Yuka Yasuoka2, Norihito Morimoto2, Hiroaki Takeuchi1,
Hiroaki Kitaoka3, Kazumasa Orihashi4 and Tetsuro Sugiura1
Abstract
Background: The aim of the present study was to evaluate the clinical utility of transthoracic echocardiography
(TTE) for screening abdominal aortic aneurysm (AAA) and to identify important TTE indices associated with AAA in
a Japanese population.
Methods: We prospectively studied 1912 patients who were referred for TTE. AAA was defined as ≥ 30 mm in size.
Results: The abdominal aorta was visualized in 95.1 % (1818/1912) by TTE. AAA was identified in 2.6 % (47/1818).
The aortic root size was significantly larger in patients with AAA than those without (36.0 ± 4.1 vs. 31.7 ± 4.2 mm,
p < 0.001). The aortic root size had a fair correlation with abdominal aortic size (r = 0.31, p < 0.001). The aortic root
size of≥ 34 mm was predictive of AAA by receiver operating characteristic curve analysis (area under the curve = 0.78,
p < 0.001). Multiple logistic regression analysis revealed that aortic root size (Hazard ratio 1.23, p < 0.001) and age
(Hazard ratio 1.05, p = 0.013) were the independent predictors of AAA.
Conclusions: The feasibility of the abdominal aortic visualization during TTE was excellent. The aortic root size
measured by TTE was the independent predictor of AAA. Screening for AAA during TTE appeared to be useful
especially in the older patients with a large (≥34 mm) aortic root.
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Background
Abdominal aortic aneurysm (AAA), an abnormal focal
dilation of the abdominal aorta, is a common and poten-
tially life-threatening condition [1]. Only a half of patient
with ruptured AAA can reach the hospital alive with an
additional high operative mortality of 49 % [2]. In asymp-
tomatic patients with AAA, elective repair of AAA is the
most effective management to prevent the rupture of AAA
with a low procedure mortality [3, 4]. Thus, early identifica-
tion and elective repair of AAA is clinically important.
Most of the patients with rupture have an undiscovered
AAA [5], because AAA is mostly asymptomatic and occult
on physical examination. Abdominal ultrasound, a fast and
safe screening method to detect AAA with high sensitivity
and specificity, is recommended for screening the patients
who are at high risk of AAA [6]. Although screening for
AAA during transthoracic echocardiography (TTE) has
been reported to be clinically useful in Western populations
[7–16], little is known about the important TTE indices
associated with the presence of AAA [12, 14, 16]. Accord-
ingly, the aim of this study was to evaluate the clinical
utility of TTE for screening AAA and to identify important
TTE indices associated with AAA in a Japanese population.
Methods
Study population
We prospectively examined 1912 consecutive patients who
were referred for routine TTE from June 2013 to May 2014
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at Kochi Medical School Hospital. Clinical data were ob-
tained by chart reviews. The study was approved by the
Ethics Committee on Human Research of the Kochi
Medical School and all the patients gave written in-
formed consent before the study. Patients with prior
AAA repair or aortic dissection were excluded from
the study.
Echocardiography
Echocardiographic evaluation of the aorta was performed
by 3 registered sonographers (M.W., D.H., and Y.Y.) in
our echocardiographic laboratory. Routine transthoracic
2-dimensional, M-mode, and Doppler echocardiography
were performed as recommended by the American Society
of Echocardiography [17]. The aortic root size was
measured at the level of the sinus of Valsalva from the
parasternal long-axis view at the onset of the QRS com-
plex. We used 4 echocardiographic equipments as follows:
1) Vivid7 (General Electric, Horten, Norway) with a 3S
transducer (1.5 to 3.6 MHz variable-frequency), 2) iE33
(Philips, Andover, MA, USA) with an S5-1 transducer (1
to 5 MHz variable-frequency), 3) Vivid Q(General Electric,
Horten, Norway) with a M4S transducer (1.5 to 3.6 MHz
variable-frequency), 4) Prosound α 7 (Hitachi-Aloka Med-
ical, Tokyo, Japan) with a UST-52105 transducer (3.5 to
5.0 MHz variable-frequency transducer).
In succession to routine TTE, the abdominal aorta was
visualized in the supine position using the same cardiac
transducer within a short period of time. First, longitudinal
image of the abdominal aorta was visualized. Secondly,
transverse image of the abdominal aorta was visualized.
The abdominal aorta was scanned from the subcostal pos-
ition and then traced distally as far as possible. Size of the
abdominal aorta was measured using still-frame images
and ‘on-line’ video calipers in diastole at the onset of the
QRS complex at the longitudinal and transverse images.
The maximal size of the abdominal aorta ≥ 30 mm in either
anteroposterior or lateral size was defined as AAA. Clinical
information was collected using the TTE requisition slip
and the electrical recording system. In randomly selected
15 patients, we measured the additional examination time
for screening AAA.
Statistical analysis
Categorical variables were presented as total number
and % of patients, and continuous variables were pre-
sented as means ± standard deviation. Clinical and TTE
indices between the 2 groups were compared with chi-
square test for categorical variables and Wilcoxon rank-
sum test for continuous variables. Correlation between
the aortic root and the abdominal aorta sizes was evalu-
ated using linear regression analysis. Receiver operating
characteristic curve analysis was used to determine the
discriminating cutoff value for predicting AAA. Multiple
logistic regression analysis was used to determine sta-
tistically significant variables associated with AAA. A
p value < 0.05 was considered statistically significant.
Data were statistically analyzed using the JMP version
11.0 software (SAS Institute Inc., Cary, NC, USA).
Results
Feasibility of AAA screening during TTE
Among 1912 patients, the abdominal aorta was visualized
in 95.1 % (1818/1912) of the patients. The additional
examination time for abdominal screening was less than a
minute; the average time for abdominal aorta screening
was 31.4 ± 12.3 (ranged from 13.0 to 53.0) seconds in
randomly selected 15 patients. TTE was performed with
Vivid7 in 36 %, with iE33 in 34 %, with Vivid Q in 17 %,
and with Prosound α 7 in 13 % of the patients.
Patient characteristics
We analyzed 1818 patients in whom adequate visualization
of the abdominal aorta were obtained. Forty-one percent
(746/1818) were inpatients and 49 % (897/1818) were men
with a mean age of 67.4 ± 15.8 years. The clinical and echo-
cardiographic diagnosis of the study patients were: ischemic
heart disease (24 %), valvular disease (23 %), myocardial
disease (22 %), arrhythmia (7 %), congenital heart disease
(3 %), ventricular hypertrophy (3 %), pulmonary hyperten-
sion (2 %), cardiac mass (1 %), normal echocardiogram
(12 %) and others (3 %). The mean size of the abdominal
aorta was 17.2 ± 5.5 mm.
Prevalence of AAA
AAA was identified in 2.6 % (47/1818). The prevalence of
AAA was 3.9 % (35/897) in men and 1.3 % (12/921) in
women (p < 0.001). The mean size of AAA was 43.6 ± 10.7
(30.0 to 90.0) mm, with 34 patients (72.3 %) having an
aortic diameter ≥ 40 mm. Of the 47 patients with AAA,
29.7 % (14/47) underwent surgical repair or endovascular
aortic stent graft insertion during 12 months following the
TTE. AAA was previously known in 30 patients and
unknown in 17 patients. Thirty-four of the 47 patients
with AAA (72 %) had a prior or current history of smok-
ing, 33 (70 %) had hypertension, and 26 (55 %) had ische-
mic heart disease.
Clinical and TTE indices associated with the presence of
AAA
Clinical and TTE indices in patients with and without
AAA are shown in Table 1. The patients with AAA were
significantly older than those without (77 ± 9 vs. 67 ±
16 years, p < 0.001). AAA was not found before the age of
54 years. AAA was significantly more frequent in male
patients than female patients. The prevalence of AAA in
male patients aged ≥ 55 years was 4.6 % (35/765).
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There were significant differences in the aortic root
size, left ventricular (LV) posterior wall thickness, LV
end-diastolic dimension, LV end-systolic dimension, LV
fractional shortening, LV mass, early diastolic LV inflow
velocity, early diastolic LV inflow velocity/ late diastolic
LV inflow velocity, early diastolic septal mitral annular
velocity, and systolic septal mitral annular velocity be-
tween patients with and without AAA.
The aortic root size measured by TTE was significantly
larger in patients with AAA than those without (36.0 ± 4.1
vs. 31.7 ± 4.2 mm, p < 0.001) (Fig. 1). All patients with AAA
had aortic root size of ≥ 28 mm. The aortic root size corre-
lated significantly with the abdominal aortic size (r = 0.31,
p < 0.001) (Fig. 2). The aortic root size of ≥ 34 mm was
predictive of AAA by receiver operating characteristic
curve analysis (area under the curve = 0.78, sensitivity:
70 %, specificity: 70 %, p < 0.001). Multiple logistic re-
gression analysis using 12 variables revealed that aortic
root size (Hazard ratio 1.23, p < 0.001) and age (Hazard
ratio 1.05, p = 0.013) were the independent predictors
of AAA (Table 2).
Discussion
The present study had 3 major findings. First, the feasi-
bility of the abdominal aortic visualization during TTE
was excellent (95.1 %). Second, the prevalence of AAA
during TTE was 2.6 %. Third, the aortic root size mea-
sured by TTE was the independent predictor of AAA.
Reynolds T et al. firstly reported in 1990 that evaluation
of the abdominal aorta should be carried out during a rou-
tine TTE examination [18]. Afterwards, other authors have
reported usefulness of TTE for screening AAA [7–16],
because of excellent feasibility and relatively high preva-
lence of AAA.
The success rate of abdominal aortic imaging during
TTE has been reported to range from 79 to 96 % with an
additional time range from 0.5 to 8 min for examination
[7–16]. In the present study, we used the same cardiac
transducer, so that no additional equipment was required.
Table 1 Comparison of clinical and echocardiographic indices
Variables AAA AAA p value
(+) (-)
Age (years) 77 ± 9 67 ± 16 <0.001
Men, n (%) 35(75 %) 862(49 %) 0.001
Aortic root (mm) 36.0 ± 4.1 31.7 ± 4.2 <0.001
Left atrium (mm) 37.3 ± 6.9 38.1 ± 7.7 0.664
Interventricular septal thickness
(mm)
9.7 ± 1.4 9.6 ± 2.0 0.323
LV posterior wall thickness (mm) 9.7 ± 1.1 9.3 ± 1.5 0.018
LV end-diastolic dimension (mm) 47.8 ± 4.3 46.2 ± 6.1 0.010
LV end-systolic dimension (mm) 31.0 ± 5.5 28.8 ± 7.0 0.001
LV fractional shortening (%) 34.9 ± 7.8 37.8 ± 8.5 0.001





E (cm/sec) 59.6 ± 18.1 70.6 ± 23.8 0.001
A (cm/sec) 85.3 ± 25.2 79.6 ± 24.6 0.192
E/A 0.75 ± 0.37 0.93 ± 0.47 0.001





E’ (cm/sec) 5.3 ± 1.8 6.6 ± 2.5 0.001
A’ (cm/sec) 9.5 ± 2.3 9.3 ± 2.3 0.960
S’ (cm/sec) 6.4 ± 1.8 7.0 ± 1.9 0.022
E/E’ 12.2 ± 5.9 11.8 ± 5.6 0.568
Data are presented as mean ± SD or n (%). LV, left ventricular. E, Early diastolic
LV inflow velocity; A, Late diastolic LV inflow velocity; E’, early diastolic septal
mitral annular velocity; A’, late diastolic septal mitral annular velocity; S’,
systolic septal mitral annular velocity; TTE = Transthoracic echocardiography;














Fig. 1 The aortic root size in patients with and without AAA. The
aortic root size was significantly larger in patients with AAA than
those without (36.0 ± 4.1 vs. 31.7 ± 4.2 mm, p < 0.001). All patients
with AAA had the aortic root size of≥ 28 mm. AAA = abdominal
aortic aneurysm
















r = 0.31, p < 0.001
Fig. 2 Correlation between the aortic root and the abdominal aorta
sizes. The aortic root size correlated significantly with the abdominal
aortic size (r = 0.31, p < 0.001)
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Moreover, an additional examination time for abdominal
visualization was less than a minute in randomly selected
15 patients. These results suggest that screening of the
abdominal aorta during TTE is feasible with minimal
additional time and cost compared to separate abdominal
ultrasound examination.
The prevalence of AAA during TTE has been reported
to range from 2.2 % to 6.5 % in Western countries [7–16],
whereas the prevalence of AAA using abdominal ultra-
sound ranged from 3.0 % to 8.0 % from population screen-
ing surveys in Western countries [19]. Therefore, previous
studies have demonstrated that screening for AAA during
TTE is clinically useful [7–16]. However, Seelig MH et al.
demonstrated that TTE performed in a highly selected
cardiac patient group in a tertiary referral center is not a
useful tool for screening clinically unsuspected AAA [20],
because the prevalence of AAA was low (0.8 %) and only
16 % of the patients with AAA underwent surgical repair
following TTE. In Korean population [21], detection rate
of AAA was 0.5 % during TTE indicating that the preva-
lence of AAA in Asia is lower than that in Western coun-
tries. Despite the low prevalence of AAA, a routine
examination of the abdominal aorta during TTE appeared
to be an effective preventive strategy for life-threatening
but asymptomatic AAA, because 26 % of the patients with
AAA underwent surgical repair or endovascular aortic
stent graft insertion following the TTE. In the present
study, the prevalence of AAA during TTE was 2.6 %.
Moreover, 30 % of the patients of the present study with
AAA underwent aortic repair following the TTE. These
results suggest that screening for AAA during TTE also
appeared to be clinically useful in a Japanese population.
Among the TTE indices associated with the presence
of AAA, LV hypertrophy, LV dilatation, or low LV frac-
tional shortening are likely relate to hypertension; 70 %
of the patients with AAA had hypertension. Although
Bekkers SC et al. reported that patients with AAA had
dilated ascending aorta [12], little is known about the
clinical importance of the aortic root size in association
with AAA [14, 22]. Recently, Aboyans et al. have re-
ported that the ascending aorta is larger in patients with
AAA than those without by univariate analysis [16],
though it is unknown about the exact position of meas-
urement of the ascending aorta. Agricola E et al. have also
demonstrated a high prevalence of dilatation/aneurysm of
the ascending aorta and the aortic arch in patients with
AAA evaluated by TTE [23]. These studies suggest a sig-
nificant correlation between dilatation of the ascending
aorta and the arch and AAA. However, discriminating
cutoff value of the ascending aortic size for predicting
AAA was not determined. Multivariate analysis was also
not used to determine the significance of the ascending
aortic size in association with AAA. Thus, it still remains
unknown whether the ascending aortic size is important
TTE indices for screening AAA.
In contrast, we measured the aortic root size at the level
of the sinus of Valsalva. The aortic root size of ≥ 34 mm
was predictive of AAA by receiver operating characteristic
curve analysis. The aortic root size was the independent
TTE index associated with the presence of AAA. As the
common risk factors for AAA and atherosclerosis may
lead to the aortic root dilatation, considering the fact that
aortic root size and age were independent predictors of
AAA, our study indicate that screening for AAA during
TTE can be useful especially in the older patients with a
large (≥34 mm) aortic root size. Although screening for
AAA during TTE has been reported to be useful [7–16],
the screening limiting to the older patients with a large
(≥34 mm) aortic root size can be clinically efficient.
The present study has several limitations. First, the inci-
dence of AAA depends on patient selection. However, the
prevalence of AAA of 2.6 % in the present study was not
significantly different of that reported in Western coun-
tries (2.2 % to 6.5 %). Second, AAA was incidentally
discovered before the present study at least in 18 patients
(60 %) as the result of other abdominal imaging studies
obtained to evaluate an unrelated condition such as spine
magnetic resonance imaging, computed tomography, or
abdominal ultrasound, though the reasons for diagnosis of
AAA were not available in the other 12 patients. The
increasing use of imaging modalities has revealed asymp-
tomatic and previously undiagnosed AAA. Therefore, we
did not exclude patients with previously known AAA.
Third, the atherosclerotic risk factors in patients with AAA
were only available concerning a prior or current history of
smoking, hypertension, and ischemic heart disease in the
Table 2 Multiple logistic regression analysis for predicting AAA
Variables Hazard ratio 95 % CI p value
Age (years) 1.05 1.01-1.09 0.013
Men, n (%) 1.27 0.57-2.90 0.562
Aortic root (mm) 1.23 1.13-1.33 <0.001
LV posterior wall thickness (mm) 1.55 0.93-2.67 0.10
LV end-diastolic dimension (mm) 1.23 0.98-1.53 0.067
LV end-systolic dimension (mm) 0.90 0.75-1.14 0.352
LV fractional shortening (%) 0.94 0.86-1.06 0.242
LV mass (g) 0.98 0.95-0.99 0.054
E (cm/sec) 1.00 0.97-1.02 0.741
E/A 0.68 0.17-1.70 0.489
E’ (cm/sec) 0.92 0.69-1.18 0.558
S’ (cm/sec) 0.86 0.66-1.10 0.235
Data are presented as mean ± SD or n (%). LV, left ventricular. E, Early diastolic
LV inflow velocity; A, Late diastolic LV inflow velocity; E’, early diastolic septal
mitral annular velocity; A’, late diastolic septal mitral annular velocity; S’,
systolic septal mitral annular velocity; AAA = abdominal aortic aneurysm; CI,
confidence interval
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present study. Moreover, the atherosclerotic risk factors in
patients without AAA were not available. The lack of infor-
mation on the prevalence of traditional risk factors for
atherosclerosis in patients with and without AAA does not
allow stratifying the patients more likely to have AAA,
according to atherosclerotic risk profile. Fourth, early detec-
tion of small AAA during TTE could cause needless disease
labeling and anxiety resulting in psychological harm.
Further studies are required to verify the clinical usefulness,
cost-effectiveness, and psychological harm of AAA screen-
ing during TTE in different healthcare settings.
Conclusions
Visualization of the abdominal aorta during TTE is feasible
with little additional time and cost. The aortic root size was
the important TTE index associated with the presence of
AAA. Screening for AAA during TTE was especially useful
in the older patients with a large (≥34 mm) aortic root size.
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